These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 15194579

  • 1. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M, Bootsma H, Van Der Geld Y, Limburg PC, Kallenberg CG, Van Rijswijk MH.
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [Abstract] [Full Text] [Related]

  • 2. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M.
    Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
    [Abstract] [Full Text] [Related]

  • 3. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
    Voss A, Nielsen EH, Svehag SE, Junker P.
    J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
    [Abstract] [Full Text] [Related]

  • 4. Acute phase proteins in salmonids: evolutionary analyses and acute phase response.
    Jensen LE, Hiney MP, Shields DC, Uhlar CM, Lindsay AJ, Whitehead AS.
    J Immunol; 1997 Jan 01; 158(1):384-92. PubMed ID: 8977214
    [Abstract] [Full Text] [Related]

  • 5. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein.
    Kumon Y, Loose LD, Birbara CA, Sipe JD.
    J Rheumatol; 1997 Jan 01; 24(1):14-9. PubMed ID: 9002005
    [Abstract] [Full Text] [Related]

  • 6. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, Whitehead AS, Bresnihan B, Fitzgerald O.
    J Rheumatol; 2000 Jan 01; 27(1):58-63. PubMed ID: 10648018
    [Abstract] [Full Text] [Related]

  • 7. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y.
    Ann Rheum Dis; 2005 Dec 01; 64(12):1698-702. PubMed ID: 16014675
    [Abstract] [Full Text] [Related]

  • 8. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
    Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA.
    J Rheumatol; 1993 May 01; 20(5):815-21. PubMed ID: 8336307
    [Abstract] [Full Text] [Related]

  • 9. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    Lacki JK, Leszczynski P, Kelemen J, Müller W, Mackiewicz SH.
    J Med; 1997 May 01; 28(1-2):99-107. PubMed ID: 9249616
    [Abstract] [Full Text] [Related]

  • 10. Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases.
    Strachan AF, Johnson PM.
    J Clin Lab Immunol; 1982 Sep 01; 8(3):153-6. PubMed ID: 6813503
    [Abstract] [Full Text] [Related]

  • 11. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC, Harmon ME, Burlingame R, Du Clos TW.
    J Rheumatol; 2005 Mar 01; 32(3):454-61. PubMed ID: 15742436
    [Abstract] [Full Text] [Related]

  • 12. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury.
    Cho K, Pham TN, Crivello SD, Jeong J, Green TL, Greenhalgh DG.
    Shock; 2004 Feb 01; 21(2):144-50. PubMed ID: 14752288
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP, Wegelius O.
    Int J Tissue React; 1985 Feb 01; 7(5):405-7. PubMed ID: 4055265
    [Abstract] [Full Text] [Related]

  • 14. The acute phase response in breast carcinoma.
    O'Hanlon DM, Lynch J, Cormican M, Given HF.
    Anticancer Res; 2002 Feb 01; 22(2B):1289-93. PubMed ID: 12168939
    [Abstract] [Full Text] [Related]

  • 15. Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy.
    Scheinberg MA, Masuda A, Benson MD, Mendes NF.
    Int J Lepr Other Mycobact Dis; 1979 Jun 01; 47(2):133-7. PubMed ID: 572349
    [Abstract] [Full Text] [Related]

  • 16. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation.
    Zahedi K, Whitehead AS.
    J Immunol; 1989 Nov 01; 143(9):2880-6. PubMed ID: 2809211
    [Abstract] [Full Text] [Related]

  • 17. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
    Pertovaara M, Jylhävä J, Uusitalo H, Pukander J, Helin H, Hurme M.
    J Rheumatol; 2009 Nov 01; 36(11):2487-90. PubMed ID: 19833744
    [Abstract] [Full Text] [Related]

  • 18. Serum amyloid protein (SAP) as a marker of autoimmune disease in mice.
    Ozmen L, Singer M, Garotta G.
    J Biol Regul Homeost Agents; 1994 Nov 01; 8(3):92-8. PubMed ID: 7754795
    [Abstract] [Full Text] [Related]

  • 19. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
    Bokarewa M, Abrahamson M, Levshin N, Egesten A, Grubb A, Dahlberg L, Tarkowski A.
    J Rheumatol; 2007 Jun 01; 34(6):1293-301. PubMed ID: 17552057
    [Abstract] [Full Text] [Related]

  • 20. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
    Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS.
    Arthritis Rheum; 2003 Oct 01; 48(10):2888-97. PubMed ID: 14558095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.